![](/img/cover-not-exists.png)
THE SGLT2 INHIBITOR EMPAGLIFLOZIN IMPROVES DIASTOLIC FUNCTION IN A HEART FAILURE MODEL MEDIATED VIA ENHANCED MYOCARDIAL KETONE METABOLISM
Santos-Gallego, Carlos G., Garcia-Ropero, Alvaro, Antonio, Rodolfo San, Requena-Ibanez, Juan Antonio, Picatoste, Belén, Smoller, Rebecca, Watanabe, Shin, Salvo, Angel Sanz, Hajjar, Roger, Ishikawa, KiVolume:
73
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(19)31292-6
Date:
March, 2019
File:
PDF, 180 KB
english, 2019